Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: May 4, 2011

Premium

Life Technologies has named Ora Hirsch Pescovitz to serve on its board of directors. Pescovitz, who will replace W. Ann Reynolds, is executive VP for medical affairs and Health Systems CEO at the University of Michigan. She formerly was associate dean for research affairs at Indiana University School of Medicine and president and CEO of Riley Hospital for Children.


Illumina CFO Christian Henry said during a quarterly earnings call that the company has appointed Kevin Williams to be its new senior director of investor relations, a position he will take over incrementally over the coming quarter from Peter Fromen. Fromen will move into a new position at Illumina as senior director of applications marketing.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.